Nonclassical vitamin D action

Armin Zittermann, Jan F Gummert, Armin Zittermann, Jan F Gummert

Abstract

It is becoming increasingly clear that vitamin D has a broad range of actions in the human body. Besides its well-known effects on calcium/phosphate homeostasis, vitamin D influences muscle function, cardiovascular homeostasis, nervous function, and the immune response. Vitamin D deficiency/insufficiency has been associated with muscle weakness and a high incidence of various chronic diseases such as cardiovascular disease, cancer, multiple sclerosis, and type 1 and 2 diabetes. Most importantly, low vitamin D status has been found to be an independent predictor of all-cause mortality. Several recent randomized controlled trials support the assumption that vitamin D can improve muscle strength, glucose homeostasis, and cardiovascular risk markers. In addition, vitamin D may reduce cancer incidence and elevated blood pressure. Since the prevalence of vitamin D deficiency/insufficiency is high throughout the world, there is a need to improve vitamin D status in the general adult population. However, the currently recommended daily vitamin D intake of 5-15 µg is too low to achieve an adequate vitamin D status in individuals with only modest skin synthesis. Thus, there is a need to recommend a vitamin D intake that is effective for achieving adequate circulating 25-hydroxyvitamin D concentrations (>75 nmol/L).

Keywords: cancer; cardiovascular; diet; mortality; ultraviolet B radiation; vitamin D.

Figures

Figure 1
Figure 1
Suggested association of vitamin D deficiency/insufficiency with chronic diseases.

References

    1. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Stuck A.E., Staehelin H.B., Orav E.J., Thoma A., Kiel D.P., Henschkowski J. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 2009;169:551–561.
    1. McKenna M.J. Differences in vitamin D status between countries in young adults and the elderly. Am. J. Med. 1992;93:69–77.
    1. Zittermann A. Vitamin D in preventive medicine - are we ignoring the evidence. Br. J. Nutr. 2003;89:552–572. doi: 10.1079/BJN2003837.
    1. Vieth R. Vitamin D and cancer mini-symposium: the risk of additional vitamin D. Ann. Epidemiol. 2009;19:441–445.
    1. Patel M., Dimaano R., Li-Ng M., Talwar S.A., Mikhail M., Pollack S., Yeh J.K. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am. J. Clin. Nutr. 2008;87:1952–1958.
    1. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007;357:266–281.
    1. Holick M.F. McCollum Award Lecture, Vitamin D: New horizons for the 21st centur. Am. J. Clin. Nutr. 1994;60:619–630.
    1. Clemens T.L., Adams J.S., Henderson S.L., Holick M.F. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet. 1982;1:74–76.
    1. Krause R., Bohring M., Hopfenmüller W., Holick M.F., Sharma A.M. Ultraviolet B and blood pressure. Lancet. 1998;352:709–710.
    1. Stamp T.C., Haddad J.G., Twigg C.A. Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet. 1977;1:1341–1343.
    1. Zittermann A., Frisch S., Berthold H.K., Götting C., Kuhn J., Kleesiek K., Stehle P., Koertke H., Koerfer R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular risk markers. Am. J. Clin. Nutr. 2009;89:1321–1327.
    1. Zittermann A., Koerfer R. Protective and toxic effects of vitamin D on vascular calcification: clinical implications. Mol. Aspects Med. 2008;29:423–432. doi: 10.1016/j.mam.2008.04.002.
    1. Antoniucci D.M., Yamashita T., Portaloe A.A. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J. Clin. Endocrinol. Metab. 2006;91:3144–3149.
    1. Bouillon R., Carmeliet G., Verlinden L., van Etten E., Verstuyf A., Luderer H.F., Lieben L., Mathieu C., Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 2008;29:726–776. doi: 10.1210/er.2008-0004.
    1. Hewison M., Burke F., Evans K.N., Lammas D.A. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J. Steroid Biochem. Mol. Biol. 2007;103:316–321.
    1. Zittermann A., Tenderich G., Koerfer R. Vitamin D and the adaptive immune system with special emphasis to allergic reactions and allograft rejection. Inflamm. Allergy Drug Targets. 2009;8:161–168.
    1. Gallieni M., Kamimura S., Ahmed A., Bravo E., Delmez J., Slatopolsky E., Dusso A. Kinetics of monocyte 1 alpha-hydroxylase in renal failure. Am. J. Physiol. 1995;268:F746–F753.
    1. Zittermann A., Gummert J.F., Boergermann J. Vitamin D deficiency and mortality. Curr. Opin. Nutr. Metab. Care. 2009;2:634–639.
    1. Mithal A., Wahl D.A., Bonjour J.P., Burckhardt P., Dawson-Hughes B., Eisman J.A., El-Hajj Fuleihan G., Josse R.G., Lips P., Morales-Torres J. IOF Committee of Scientific Advisors. (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20:1807–1820. doi: 10.1007/s00198-009-0954-6.
    1. Moreira-Pfrimer L.D., Pedrosa M.A., Teixeira L., Lazaretti-Castro M. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann. Nutr. Metab. 2009;54:291–300.
    1. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B., Orav J.E., Stuck A.E., Theiler R., Wong J.B., Egli A., Kiel D.P., Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. [Oct 1];BMJ. 2009 339:b3692.
    1. Ronge H.E. Increase of physical effectiveness by systematic ultraviolet radiation. Strahlentherapie. 1952;88:563–566. [article in German]
    1. Schauber J., Dorschner R.A., Coda A.B., Büchau A.S., Liu P.T., Kiken D., Helfrich Y.R., Kang S., Elalieh H.Z., Steinmeyer A., Zügel U., Bikle D.D., Modlin R.L., Gallo R.L. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 2007;117:803–811.
    1. Nnoaham K.E., Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol. 2008;37:113–119.
    1. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F., Giovannucci E. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006;134:1129–1140.
    1. Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 2010 Epub ahead of print.
    1. Laaksi I., Ruohola J.P., Tuohimaa P., Auvinen A., Haataja R., Pihlajamäki H., Ylikomi T. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am. J. Clin. Nutr. 2007;86:714–717.
    1. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2009;169:384–390.
    1. Avenell A., Cook J.A., Maclennan G.S., Macpherson G.C. Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438) Age Ageing. 2007;36:574–577.
    1. Aloia J.F., Talwar S.A., Pollack S., Yeh J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch. Intern. Med. 2005;165:1618–1623.
    1. Li-Ng M., Aloia J.F., Pollack S., Cunha B.A., Mikhail M., Yeh J., Berbari N. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol. Infect. 2009;137:1396–1404.
    1. Yamshchikov A.V., Desai N.S., Blumberg H.M., Ziegler T.R., Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr. Pract. 2009;15:438–449.
    1. Misawa Y., Baba A., Ito S., Tanaka M., Shiohara M. Vitamin D(3) induces expression of human cathelicidin antimicrobial peptide 18 in newborns. [Nov 28];Int. J. Hematol. 2009 [Epub ahead of print]
    1. Wjst M. Another explanation for the low allergy rate in the rural Alpine foothills. Clin. Mol. Allergy. 2005;3:7.
    1. Von Mutius E. Influences in allergy: epidemiology and the environment. J. Allergy Clin. Immunol. 2004;113:373–379.
    1. Gale C.R., Robinson S.M., Harvey N.C., Javaid M.K., Jiang B., Martyn C.N., Godfrey K.M., Cooper C. the Princess Anne Hospital Study Group. Maternal vitamin D status during pregnancy and childhood outcomes. Eur. J. Clin. Nutr. 2008;62:68–77. doi: 10.1038/sj.ejcn.1602680.
    1. Hyppönen E., Sovio U., Wjst M., Patel S., Pekkanen J., Hartikainen A.L., Järvelinb M.R. Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann. N. Y. Acad. Sci. 2004;1037:84–95.
    1. Bäck O., Blomquist H.K., Hernell O., Stenberg B. Does vitamin D intake during infancy promote the development of atopic allergy. Acta Derm. Venereol. 2009;89:28–32.
    1. Wjst M., Hyppönen E. Vitamin D serum levels and allergic rhinitis. Allergy. 2007;62:1085–1086.
    1. Zittermann A., Dembinski J., Stehle P. Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin 10. Pediatr. Allergy Immu. 2004;15:242–246.
    1. Camargo C.A., Rifas-Shiman S.L., Litonjua A.A., Rich-Edwards J.W., Weiss S.T., Gold D.R., Kleinman K., Gillman M.W. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am. J. Clin. Nutr. 2007;85:788–795.
    1. Camargo C.A., Clark S., Kaplan M.S., Lieberman P., Wood R.A. Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D. J. Allergy Clin. Immunol. 2007;120:131–136.
    1. Oren E., Banerji A., Camergo C.A. Vitamin D and atopic disoerdes in an obese population screened for vitamin D deficiency. J. Allergy Immunol. 2008;121:533–534.
    1. Erkkola M., Kaila M., Nwaru B.I., Kronberg-Kippilä C., Ahonen S., Nevalainen J., Veijola R., Pekkanen J., Ilonen J., Simell O., Knip M., Virtanen S.M. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin. Exp. Allergy. 2009;39:875–882.
    1. Sidbury R., Sullivan A.F., Thadhani R.I., Camargo C.A. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br. J. Dermatol. 2008;159:245–247.
    1. Schleithoff S.S., Zittermann A., Tenderich G., Berthold H.K., Stehle P., Koerfer R. Vitamin D Supplementation Improves Cytokine Profile In Patients With Congestive Heart Failure: A Double-Blind, Randomized, Placebo-Controlled Trial. Am. J. Clin. Nutr. 2006;83:754–759.
    1. Hyppönen E., Berry D.J., Wjst M., Power C. Serum 25-hydroxyvitamin D and IgE - a significant but nonlinear relationship. Allergy. 2009;64:613–620. doi: 10.1111/j.1398-9995.2008.01865.x.
    1. World Health Organization. International Agency for Research on Cancer. Vitamin D and cancer. IARC Working Group Reports. Vol. 5. WHO; Geneva, Switzerland: 2008. p. 148.
    1. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 2007;85:1586–1591.
    1. Gorham E.D., Mohr S.B., Garland F.C., Garland C.F. Vitamin D for Cancer Prevention and Survival. Clin. Rev. Bone Miner Metab. 2009;7:159–175.
    1. Garland C.F., Gorham E.D., Mohr S.B., Garland F.C. Vitamin D for cancer prevention: global perspective. Ann. Epidemiol. 2009;19:468–483.
    1. Tuohimaa P., Tenkanen L., Ahonen M., Lumme S., Jellum E., Hallmans G., Stattin P., Harvei S., Hakulinen T., Luostarinen T., Dillner J., Lehtinen M., Hakama M. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int. J. Cancer. 2004;108:104–108. doi: 10.1002/ijc.11375.
    1. Zittermann A., Grant W.B. 25-hydroxyvitamin D levels and all-cause mortality. Arch. Intern. Med. 2009;169:1075–1076.
    1. Mohr S.B., Garland C.F., Gorham E.D., Garland F.C. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwid. Diabetologia. 2008;51:1391–1398.
    1. Hyppönen E., Läärä E., Reunanen A., Järvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358:1500–1503.
    1. Zipitis C.S., Akobeng A.K. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child. 2008;93:512–517.
    1. Li X., Liao L., Yan X., Huang G., Lin J., Lei M., Wang X., Zhou Z. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA) Diabetes Metab. Res. Rev. 2009;25:411–416.
    1. Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2007;92:2017–2029. doi: 10.1210/jc.2007-0298.
    1. Jorde R Figenschau., Y. Supplementation with cholecalciferol does not improve glycemic control in diabtetic subjects with normal serum 25-hydroxyvitamin D levels. Eur. J. Nutr. 2009;48:349–354. doi: 10.1007/s00394-009-0020-3.
    1. von Hurst P.R., Stonehouse W., Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br. J. Nutr. 2009:1–7. [Epub ahead of print]
    1. Zittermann A. Koerfer R.Vitamin D in the prevention and treatment of coronary heart disease. Curr. Opin. Clin. Nutr. Metab. Care. 2008;11:752–757. doi: 10.1097/MCO.0b013e328312c33f.
    1. Witham M.D., Nadir M.A., Struthers A.D. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 2009;27:1948–1954.
    1. Pilz S., Dobnig H., Fischer J.E., Wellnitz B., Seelhorst U., Boehm B.O., März W. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke. 2008;39:2611–2613.
    1. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., Benjamin E.J., D'Agostino R.B., Wolf M., Vasan R.S. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–511.
    1. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 2008;168:1174–1180.
    1. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., Kinkeldei J., Boehm B.O., Weihrauch G., Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 2008;168:1340–1349.
    1. Pilz S., Dobnig H., Nijpels G., Heine R.J., Stehouwer C.D., Snijder M.B., van Dam R.M., Dekker J.M. Vitamin D and mortality in older men and women. Clin. Endocrinol. 2009;71:666–672.
    1. Ginde A.A., Scragg R., Schwartz R., Camargo C.A. Prospective Study of Serum 25-Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All-Cause Mortality in Older U.S. Adults. J. Am. Geriatr. Soc. 2009;57:1595–1603. doi: 10.1111/j.1532-5415.2009.02359.x.
    1. LaCroix A.Z., Kotchen J., Anderson G., Brzyski R., Cauley J.A., Cummings S.R., Gass M., Johnson K.C., Ko M., Larson J., Manson J.E., Stefanick M.L., Wactawski-Wende J. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J. Gerontol. A Biol. Sci. Med. Sci. 2009;64:559–567.
    1. Wang L., Manson J.E., Song Y., Sesso H.D. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. ntern. Med. 2010;152:315–323.
    1. Zittermann A., Frisch S., Berthold H.K., Götting C., Kuhn J., Kleesiek K. , Stehle P., Koertke H, Koerfer R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular risk markers. Am. J. Clin. Nutr. 2009;89:1321–1327. doi: 10.3945/ajcn.2008.27004.
    1. Chaudhuri A. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med. Hypotheses. 2005;64:608–618.
    1. Embry A.F., Snowdon L.R., Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann. Neurol. 2000;48:271–272.
    1. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296:2832–2838.
    1. Ramagopalan S.V., Maugeri N.J., Handunnetthi L., Lincoln M.R., Orton S.M., Dyment D.A., Deluca G.C., Herrera B.M., Chao M.J., Sadovnick A.D., Ebers G.C., Knight J.C. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009;5:e1000369.
    1. Autier P., Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 2007;167:1730–1737.
    1. Kuroda T., Shiraki M., Tanaka S., Ohta H. Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women. Bone. 2009;44:168–172.
    1. Ng K., Meyerhardt J.A., Wu K., Feskanich D., Hollis B.W., Giovannucci E.L., Fuchs C.S. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J. Clin. Oncol. 2008;26:2984–2991.
    1. Wang A.Y., Lam C.W., Sanderson J.E., Wang M., Chan I.H., Lui S.F., Sea M.M., Woo J. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am. J. Clin. Nutr. 2008;87:1631–1638.
    1. Heist R.S., Zhou W., Wang Z. Liu, G., Neuberg D., Su L., Asomaning K., Hollis B.W., Lynch T.J., Wain J.C., Giovannucci E., Christiani D.C. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J. Clin. Oncol. 2008;26:5596–5602.
    1. Jorde R., Sneve M., Torjesen P., Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D for 1 year. J. Intern. Med. 2009 [epub ahead of print]
    1. Holmes V.A., Barnes M.S., Alexander H.D., McFaul P., Wallace J.M. Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. Br. J. Nutr. 2009;102:876–881. doi: 10.1017/S0007114509297236.
    1. Standing Committee of European Doctors. Vitamin D nutritional policy in Europe. [(assessed on 24 March 2010)]. Available online: .
    1. Zittermann A., Koerfer R. Protective and toxic effects of vitamin D on vascular calcification: Clinical implications. Mol. Aspects Med. 2008;29:423–432. doi: 10.1016/j.mam.2008.04.002.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi